Marc Robillard
CSO and Founder Tagworks Pharmaceuticals BV
Seminars
Monday 12th October 2026
Breaking Down Learnings From TGW101 Unique PK & Improved Safety Profile & Application to Next Generation Click-Cleavable ADCs
12:00 pm
- Breaking down rationale and mechanism for click-to-release chemistry to develop ADCs with reduced off-target toxicity
- Highlighting key toxicity and PK aspects from the TGW101 program to support the safety benefits of the Click-to-Release ADC approach
- Bringing learnings from TGW101 improved safety profile to ongoing ADC discovery across targets, protein formats and payloads to advance click-cleavable ADCs with mechanism-driven improved tolerability and therapeutic index
